Clinical review report: Sucroferric Oxyhydroxide (Velphoro) (Vifor Fresenius Medical Care Renal Pharma Ltd.) indication : for the control of serum phosphorus levels in adult patients with end-stage renal disease on dialysis
The objective of this report was to perform a systematic review of the beneficial and harmful effects of sucroferric oxyhydroxide to control serum phosphorus levels in adult patients with end-stage renal disease on dialysis
Corporate Author: | |
---|---|
Format: | eBook |
Language: | English |
Published: |
Ottawa (ON)
CADTH
February 2019, 2019
|
Edition: | Final |
Series: | CADTH common drug review
|
Subjects: | |
Online Access: | |
Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Table of Contents:
- Includes bibliographical references